Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11751767rdf:typepubmed:Citationlld:pubmed
pubmed-article:11751767lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11751767lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:11751767lifeskim:mentionsumls-concept:C0014834lld:lifeskim
pubmed-article:11751767lifeskim:mentionsumls-concept:C0033581lld:lifeskim
pubmed-article:11751767lifeskim:mentionsumls-concept:C0008809lld:lifeskim
pubmed-article:11751767lifeskim:mentionsumls-concept:C0034428lld:lifeskim
pubmed-article:11751767lifeskim:mentionsumls-concept:C0015219lld:lifeskim
pubmed-article:11751767lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:11751767lifeskim:mentionsumls-concept:C0206173lld:lifeskim
pubmed-article:11751767lifeskim:mentionsumls-concept:C0439590lld:lifeskim
pubmed-article:11751767pubmed:issue1lld:pubmed
pubmed-article:11751767pubmed:dateCreated2001-12-25lld:pubmed
pubmed-article:11751767pubmed:abstractTextThe emergence and evolution of quinolone-resistant Escherichia coli in faeces of patients with prostatitis treated with high-dose oral ciprofloxacin for 1 month were studied. In 11 of 23 patients, from whom only quinolone-susceptible E. coli was isolated before treatment, quinolone-resistant strains, genetically distinct from the quinolone-susceptible ones, predominated during and just after therapy. Two months after treatment, these were completely displaced by quinolone-susceptible E. coli, genetically distinct from the E. coli isolated before and during therapy. Hence, during ciprofloxacin therapy, half of the patients were transiently colonized with new, quinolone-resistant strains of E. coli.lld:pubmed
pubmed-article:11751767pubmed:languageenglld:pubmed
pubmed-article:11751767pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11751767pubmed:citationSubsetIMlld:pubmed
pubmed-article:11751767pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11751767pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11751767pubmed:statusMEDLINElld:pubmed
pubmed-article:11751767pubmed:monthJanlld:pubmed
pubmed-article:11751767pubmed:issn0305-7453lld:pubmed
pubmed-article:11751767pubmed:authorpubmed-author:HorcajadaJuan...lld:pubmed
pubmed-article:11751767pubmed:authorpubmed-author:VilaJordiJlld:pubmed
pubmed-article:11751767pubmed:authorpubmed-author:Moreno-Martín...lld:pubmed
pubmed-article:11751767pubmed:authorpubmed-author:RuizJoaquimJlld:pubmed
pubmed-article:11751767pubmed:authorpubmed-author:MartínezJose...lld:pubmed
pubmed-article:11751767pubmed:authorpubmed-author:SánchezMiquel...lld:pubmed
pubmed-article:11751767pubmed:authorpubmed-author:SorianoEladio...lld:pubmed
pubmed-article:11751767pubmed:authorpubmed-author:MensaJosepJlld:pubmed
pubmed-article:11751767pubmed:issnTypePrintlld:pubmed
pubmed-article:11751767pubmed:volume49lld:pubmed
pubmed-article:11751767pubmed:ownerNLMlld:pubmed
pubmed-article:11751767pubmed:authorsCompleteYlld:pubmed
pubmed-article:11751767pubmed:pagination55-9lld:pubmed
pubmed-article:11751767pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11751767pubmed:meshHeadingpubmed-meshheading:11751767...lld:pubmed
pubmed-article:11751767pubmed:meshHeadingpubmed-meshheading:11751767...lld:pubmed
pubmed-article:11751767pubmed:meshHeadingpubmed-meshheading:11751767...lld:pubmed
pubmed-article:11751767pubmed:meshHeadingpubmed-meshheading:11751767...lld:pubmed
pubmed-article:11751767pubmed:meshHeadingpubmed-meshheading:11751767...lld:pubmed
pubmed-article:11751767pubmed:meshHeadingpubmed-meshheading:11751767...lld:pubmed
pubmed-article:11751767pubmed:meshHeadingpubmed-meshheading:11751767...lld:pubmed
pubmed-article:11751767pubmed:meshHeadingpubmed-meshheading:11751767...lld:pubmed
pubmed-article:11751767pubmed:meshHeadingpubmed-meshheading:11751767...lld:pubmed
pubmed-article:11751767pubmed:year2002lld:pubmed
pubmed-article:11751767pubmed:articleTitleMolecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis.lld:pubmed
pubmed-article:11751767pubmed:affiliationDepartment of Infectious Diseases, Institut Clínic d'Infeccions i Immunologia (ICII), Villarroel 170, 08036 Barcelona, Spain. jhorcaja@clinic.ub.eslld:pubmed
pubmed-article:11751767pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11751767pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11751767lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11751767lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11751767lld:pubmed